Bausch Health Companies Inc. (BHC)
↓ Download CSV- Sector Manufacturing
- Incorporated NJ
- Fiscal year ends Dec 31
In fiscal 2025, Bausch Health Companies Inc. reported revenue of $10.27B, up 6.7% from the prior year. The company was profitable, with a net margin of 1.2%. It held $26.37B in total assets against $25.99B in total liabilities.
Key ratios (FY2025)
17.7%
Operating margin
1.2%
Net margin
31.8%
Return on equity
+6.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B |
| Cost of Revenue | — | — | — | — | — | — | — | — | $2.51B | $2.57B |
| Operating Income | $1.81B | $1.55B | $963.00M | $454.00M | $450.00M | $676.00M | -$203.00M | -$2.38B | $102.00M | -$566.00M |
| Net Income | $120.00M | -$72.00M | -$611.00M | -$212.00M | -$937.00M | -$559.00M | -$1.78B | -$4.14B | $2.40B | -$2.41B |
| EPS (Diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 |
| Total Assets | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B | $33.86B | $32.49B | $37.50B | $43.53B |
| Total Liabilities | $25.99B | $26.84B | $27.43B | $25.43B | $29.24B | $30.59B | $32.73B | $29.68B | $31.55B | $40.27B |
| Shareholders' Equity | $377.00M | -$322.00M | -$82.00M | $260.00M | -$34.00M | $605.00M | $1.14B | $2.81B | $5.94B | $3.26B |
| Cash & Equivalents | $1.31B | $1.18B | $947.00M | $564.00M | $582.00M | $605.00M | $3.24B | $721.00M | $720.00M | $542.00M |
| Operating Cash Flow | $1.40B | $1.60B | $1.03B | -$728.00M | $1.43B | $1.11B | $1.50B | $1.50B | $2.29B | $2.09B |
| Capital Expenditures | $397.00M | $337.00M | $215.00M | $218.00M | $269.00M | $302.00M | $270.00M | $157.00M | $171.00M | $235.00M |
| Shares Outstanding | 375.00M | 368.00M | 364.90M | 362.00M | 358.90M | 355.00M | 352.10M | 351.30M | 351.80M | 347.30M |